- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-702X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Disease-modifying effects of ranibizumab for central retinal vein occlusion ; day:6 ; month:10 ; year:2021 ; pages:1-7
Graefe's archive for clinical and experimental ophthalmology ; (6.10.2021), 1-7
- Urheber
-
Huang, Jason M.
Khurana, Rahul N.
Ghanekar, Avanti
Wang, Pin-wen
Day, Bann-Mo
Blodi, Barbara A.
Domalpally, Amitha
Quezada-Ruiz, Carlos
Ip, Michael S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00417-021-05224-x
- URN
-
urn:nbn:de:101:1-2021122318102640573187
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Huang, Jason M.
- Khurana, Rahul N.
- Ghanekar, Avanti
- Wang, Pin-wen
- Day, Bann-Mo
- Blodi, Barbara A.
- Domalpally, Amitha
- Quezada-Ruiz, Carlos
- Ip, Michael S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
Current Disease-Modifying Therapies in Multiple Sclerosis
Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusion
Real-world outcomes with ranibizumab in branch retinal vein occlusion: the prospective, global, LUMINOUS study
Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema
Disease-modifying treatments in Alzheimer’s disease
Pre-treatment clinical features in central retinal vein occlusion that predict visual outcome following intravitreal ranibizumab
Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective
Disease-modifying effects of metabolic perturbations in ALS/FTLD
Current experimental disease-modifying therapeutics for multiple system atrophy
Lithium as a disease-modifying agent for prion diseases
A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
Current Disease-Modifying Therapies in Multiple Sclerosis
Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusion
Real-world outcomes with ranibizumab in branch retinal vein occlusion: the prospective, global, LUMINOUS study
Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema
Disease-modifying treatments in Alzheimer’s disease
Pre-treatment clinical features in central retinal vein occlusion that predict visual outcome following intravitreal ranibizumab
Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective
Disease-modifying effects of metabolic perturbations in ALS/FTLD
Current experimental disease-modifying therapeutics for multiple system atrophy
Lithium as a disease-modifying agent for prion diseases
A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
Current Disease-Modifying Therapies in Multiple Sclerosis
Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusion
Real-world outcomes with ranibizumab in branch retinal vein occlusion: the prospective, global, LUMINOUS study
Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema
Disease-modifying treatments in Alzheimer’s disease
Pre-treatment clinical features in central retinal vein occlusion that predict visual outcome following intravitreal ranibizumab
Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective
Disease-modifying effects of metabolic perturbations in ALS/FTLD
Current experimental disease-modifying therapeutics for multiple system atrophy
Lithium as a disease-modifying agent for prion diseases